Free Trial
NASDAQ:PETV

PetVivo (PETV) Stock Price, News & Analysis

PetVivo logo
$0.77 +0.04 (+6.04%)
As of 01:53 PM Eastern

About PetVivo Stock (NASDAQ:PETV)

Key Stats

Today's Range
$0.70
$0.77
50-Day Range
$0.40
$0.95
52-Week Range
$0.29
$1.34
Volume
34,500 shs
Average Volume
35,695 shs
Market Capitalization
$16.29 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.

Receive PETV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PetVivo and its competitors with MarketBeat's FREE daily newsletter.

PETV Stock News Headlines

PetVivo appoints Mike Eldred as commercialization, operations advisor
Is this the pin that pops the bubble?
CEO Jensen Huang does not want you knowing this dirty little secret about Nvidia… In fact, any day now we’re expecting a cease and desist from Nvidia’s lawyers. Go here now before it’s too late to find out why Nvidia shares are slumping so hard.
See More Headlines

PETV Stock Analysis - Frequently Asked Questions

PetVivo's stock was trading at $0.62 at the start of the year. Since then, PETV stock has increased by 24.0% and is now trading at $0.7685.
View the best growth stocks for 2025 here
.

PetVivo Holdings, Inc. (NASDAQ:PETV) announced its quarterly earnings data on Thursday, June, 29th. The company reported ($0.21) EPS for the quarter, hitting analysts' consensus estimates of ($0.21). The company had revenue of $0.13 million for the quarter. PetVivo had a negative net margin of 889.99% and a negative trailing twelve-month return on equity of 1,213.96%.

Shares of PETV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that PetVivo investors own include HubSpot (HUBS), ForgeRock (FORG), Netflix (NFLX), Sportradar Group (SRAD), Dutch Bros (BROS) and ConocoPhillips (COP).

Company Calendar

Last Earnings
6/29/2023
Today
1/30/2025
Next Earnings (Estimated)
2/10/2025
Fiscal Year End
3/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:PETV
Fax
N/A
Employees
20
Year Founded
N/A

Profitability

Net Income
$-10,950,000.00
Net Margins
-889.99%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$970,000.00
Book Value
$0.07 per share

Miscellaneous

Free Float
18,904,000
Market Cap
$15.36 million
Optionable
Not Optionable
Beta
2.34
10 Best Stocks to Own in 2025 Cover

Enter your email address and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:PETV) was last updated on 1/30/2025 by MarketBeat.com Staff
From Our Partners